Roblon (One-pager): Q3'23/24 returns to positive earnings while divestment of US FOC is initiated
Read the latest Roblon One-pager update following the Q3 2023/24 results. The One-pager includes a brief description of Roblon, an update to the high-performance cable component industry outlook, latest financials, valuation perspectives relative to a peer group, and outlines several key investment risks and key investment reasons.
Roblon realised strong growth in its composite business in Q3 2023/24 (+71% y/y), but ongoing weakness in the FOC business (-10% y/y). Overall, the company returned to positive EBIT in Q3 but remains with a negative EBIT 9m’2023/24. Roblon also announced its plans to divest the US-based FOC operations and maintains its full-year guidance.
To learn more about Roblon, read the full one-pager below or catch up on the latest presentation of the H1 2023/24 event, hosted with Co-CEO and CFO Carsten Michno.
Link to event: https://www.inderes.dk/videos/roblon-praesentation-af-q2-regnskabet-202324
Disclaimer: HC Andersen Capital receives payment from Roblon for a DigitalIR/Corporate Visibility subscription agreement. / Philip Coombes 11:00 27/09/2024
Sisäänkirjautuminen vaadittu
Tämä sisältö on näkyvissä vain sisäänkirjautuneille käyttäjille
Roblon
Roblon develops high performance fiber solutions and technologies with a history dating back to 1957, when the company was founded. Roblon produces the fibers, made of fiberglass, aramid etc. that are used to reinforce and protect vital cables in various industries. The company is divided into two main business areas – Fiber Optic Cables (FOC) and Composite. The FOC segment is usually a sub-supplier to large cable producers, where the end customers are typically global internet and telecom providers. The Composite segment is usually a sub-supplier to the producers of wires and cables, which supply global oil & gas companies as well as companies that are active within wind energy. Roblon is headquartered in Frederikshavn (Denmark) and has production facilities in Gærum (Denmark), Hickory, North Carolina (USA) and the recently acquired Vamafil in the Czech Republic. Roblon is thus active with production and sales in both Europe and the USA.
Lue lisää yhtiösivulla